| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.42M | 30.48M | 26.30M | 26.79M | 15.24M | 7.78M |
| Gross Profit | 9.63M | 10.43M | 10.14M | 9.61M | 4.99M | 3.49M |
| EBITDA | 2.40M | 1.50M | 2.50M | -3.02M | 4.85M | 9.87M |
| Net Income | 635.00K | 893.00K | 933.00K | -3.12M | 3.68M | 7.62M |
Balance Sheet | ||||||
| Total Assets | 71.93M | 73.98M | 71.87M | 62.48M | 68.44M | 47.12M |
| Cash, Cash Equivalents and Short-Term Investments | 31.21M | 30.80M | 30.36M | 23.71M | 35.78M | 33.65M |
| Total Debt | 11.88M | 11.76M | 13.73M | 10.38M | 13.38M | 7.75M |
| Total Liabilities | 30.89M | 32.54M | 31.39M | 23.32M | 26.22M | 12.20M |
| Stockholders Equity | 41.04M | 41.44M | 40.47M | 39.16M | 42.22M | 34.92M |
Cash Flow | ||||||
| Free Cash Flow | 7.67M | 2.53M | -1.39M | 7.50M | 2.88M | -4.36M |
| Operating Cash Flow | 7.67M | 2.53M | -1.39M | 7.50M | 2.88M | -4.31M |
| Investing Cash Flow | -6.51M | 22.00K | 16.00K | -5.81M | -6.47M | -4.15M |
| Financing Cash Flow | -730.00K | -3.31M | 2.19M | -3.32M | 4.70M | 7.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £167.31M | 15.76 | 59.02% | 5.98% | 17.88% | 28.90% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £72.07M | 15.81 | 6.42% | 8.80% | 6.04% | -24.55% | |
54 Neutral | £339.53M | 261.22 | 0.58% | 2.31% | 10.68% | -89.58% | |
51 Neutral | £16.21M | 24.83 | 1.54% | ― | -4.67% | 590.48% | |
45 Neutral | £366.52M | -2.21 | -142.88% | ― | -7.30% | -311.68% |